Golden Sun Health Technology announced that the shareholders of the Company had approved a proposed 1-for-10 share consolidation of the Company’s ordinary shares at an extraordinary general meeting of shareholders held on April 11, 2024, at 8th Floor, Administration Building, 390 East Tiyuhui Road, Hongkou District, Shanghai, China. At the opening of trading on April 19, 2024, the Company’s class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Stock Market under the same symbol “GSUN“, but under a new CUSIP number of G4013A115. The primary objective of the Share Consolidation is to enable the Company to regain compliance with Nasdaq Listing Rule 5550(a)(2) relating to the minimum bid price per share of the Company’s Class A ordinary shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
